5-73173736-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153217.3(TMEM174):c.493G>A(p.Gly165Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153217.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM174 | NM_153217.3 | c.493G>A | p.Gly165Ser | missense_variant | 1/2 | ENST00000296776.6 | NP_694949.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM174 | ENST00000296776.6 | c.493G>A | p.Gly165Ser | missense_variant | 1/2 | 1 | NM_153217.3 | ENSP00000296776.5 | ||
TMEM174 | ENST00000511737.1 | n.425+20G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251342Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135832
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727248
GnomAD4 genome AF: 0.000118 AC: 18AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.493G>A (p.G165S) alteration is located in exon 1 (coding exon 1) of the TMEM174 gene. This alteration results from a G to A substitution at nucleotide position 493, causing the glycine (G) at amino acid position 165 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at